Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

被引:32
|
作者
Tramper-Stranders, G. A. [1 ]
van der Ent, C. K. [1 ]
Molin, S. [2 ]
Yang, L. [2 ]
Hansen, S. K. [2 ]
Rau, M. H. [2 ]
Ciofu, O. [3 ]
Johansen, H. K. [4 ,5 ]
Wolfs, T. F. W. [6 ]
机构
[1] Wilhelmina Childrens Hosp, Cyst Fibrosis Ctr, Univ Med Ctr Utrecht, Dept Paediat Resp Med, NL-3508 AB Utrecht, Netherlands
[2] Tech Univ Denmark, Infect Microbiol Grp, Ctr Syst Biol, DK-2800 Lyngby, Denmark
[3] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Danish CF Ctr, DK-2100 Copenhagen, Denmark
[6] Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands
关键词
Chronic infection; cystic fibrosis; genotyping; Pseudomonas aeruginosa; virulence; III SECRETION; PULMONARY INFECTIONS; GENETIC ADAPTATION; DCTA GENE; COLONIZATION; VIRULENCE; STRAINS; MICROEVOLUTION; INACTIVATION; PATHOGEN;
D O I
10.1111/j.1469-0691.2011.03627.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2012; 18: 567574 Abstract Despite intensive eradication therapy, some CF patients with early Pseudomonas aeruginosa infection rapidly develop a chronic infection. To elucidate factors associated with this persistence, bacterial characteristics of early P. aeruginosa isolates were analysed that were either eradicated rapidly or persisted despite multiple antimicrobial treatments. Eighty-six early infection episodes were studied. First P. aeruginosa isolates from patients with eradication (36) or persistent infection (16) were included; isolates from patients with intermittent infection (34) were omitted from the study. Virulence assays, antimicrobial resistance, cytotoxicity and mutation frequencies were analysed in vitro. P. aeruginosa was genotyped by SNP-array. Transcriptomic profiles of two eradicated and two persistent strains were compared. Nineteen per cent of patients developed persistent infection; 42% achieved eradication. Secretion of virulence factors and mutation frequencies were highly variable among both eradicated and persistent isolates and were not different between the groups. Cytotoxicity was present in 57% of eradicated vs. 100% of persistent isolates (p <0.01). None of the isolates were resistant to antibiotics. The isolates were genotypically highly diverse. Multivariate analysis showed that in vitro determined bacterial characteristics could not predict persistence after first P. aeruginosa infection. Preliminary transcriptomic data showed increased expression of some genes related to a metabolic pathway. The early onset of chronic infection was not associated with (in vitro determined) bacterial characteristics only. Although the persistent isolates were more often cytotoxic, for the individual patient it was not possible to predict the risk of persistence based on bacterial characteristics. Unknown factors such as host-pathogen and pathogen-pathogen interactions should be further explored.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [41] Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients
    Fernandez-Olmos, Ana
    Garcia-Castillo, Mara
    Maria Alba, Jose
    Isabel Morosini, Mara
    Lamas, Adelaida
    Romero, Beatriz
    Carlos Galan, Juan
    del Campo, Rosa
    Canton, Rafael
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (08) : 2761 - 2765
  • [42] Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis
    Lahiri, Thomas
    CLINICS IN CHEST MEDICINE, 2007, 28 (02) : 307 - +
  • [43] Metabolic flux analyses of Pseudomonas aeruginosa cystic fibrosis isolates
    Opperman, Michael J.
    Shachar-Hill, Yair
    METABOLIC ENGINEERING, 2016, 38 : 251 - 263
  • [44] PARENT PERCEPTIONS AND RESPONSE TO THE INITIAL PSEUDOMONAS AERUGINOSA AIRWAY INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
    Bichl, S.
    Griffiths, A.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 451 - 452
  • [45] Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis
    Zemanick, Edith T.
    Bell, Scott C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (06) : 636 - 645
  • [46] Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
    Johansen, Helle Krogh
    Gotzsche, Peter C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [47] Pseudomonas aeruginosa cross-infection in cystic fibrosis
    Jones, AM
    Webb, AK
    Govan, JRW
    Hart, CA
    Walshaw, MJ
    LANCET, 2002, 359 (9305): : 527 - 527
  • [48] Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
    Bhagirath, Anjali Y.
    Li, Yanqi
    Somayajula, Deepti
    Dadashi, Maryam
    Badr, Sara
    Duan, Kangmin
    BMC PULMONARY MEDICINE, 2016, 16
  • [49] Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
    Johansen, Helle Krogh
    Gotzsche, Peter C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (08):
  • [50] Heritability of Respiratory Infection with Pseudomonas aeruginosa in Cystic Fibrosis
    Green, Deanna M.
    Collaco, J. Michael
    McDougal, Kathryn E.
    Naughton, Kathleen M.
    Blackman, Scott M.
    Cutting, Garry R.
    JOURNAL OF PEDIATRICS, 2012, 161 (02): : 290 - +